C07K - Peptides - Patents Sitemap

More topics under "C07K - Peptides" (616,656)
C07K 1 - General processes for the preparation of peptides (51,718)
C07K 11 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (895)
C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
C07K 19 - Hybrid peptides (29,428)
C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)

Patents for C07K - Peptides (3,738)
04/2012
04/17/2012	CA2225378C Cytokine that induces apoptosis
04/11/2012	EP1503794B1 Methods of treatement using ctla-4 antibodies
04/11/2012	CN102409063A 黄病毒ns1亚单位疫苗 Flavivirus ns1 subunit vaccine
04/05/2012	US20120082636 Stabilized alpha helical peptides and uses thereof
04/03/2012	US8148600 Transgenic mouse expressing fluorescent protein for use of whole body imaging in comparative disease diagnosis and prognosis; colorimetric analysis
03/2012
03/29/2012	US20120077754 Copolymer-1 improvements in compositions of copolymers
03/27/2012	US8142778 Methods of treatment using CTLA-4 antibodies
03/22/2012	US20120070437 Method of identifying compounds that bind baff-r
03/21/2012	EP1320540B9 Peptidomimetic protease inhibitors
03/20/2012	US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012	CA2405469C Integrin binding peptide derivatives
03/15/2012	US20120064034 Peptidomimetic protease inhibitors
03/13/2012	CA2419607C Peptidomimetic protease inhibitors
03/13/2012	CA2199049C Novel pesticidal proteins and strains
03/08/2012	US20120059145 Stabilized bioactive peptides and methods of identification, synthesis, and use
03/07/2012	CN102367277A Polymer conjugates of mutated neublastin
02/2012
02/28/2012	US8124378 Murine zcytor17 ligand polynucleotides
02/21/2012	US8119783 FGF variants and methods for use thereof
02/21/2012	US8119114 Polymer conjugates of mutated neublastin
02/16/2012	US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof
02/14/2012	US8114280 Separation matrix and method of purification
02/08/2012	EP1608393B1 Ebola peptides and immunogenic compositions containing same
02/01/2012	CN101389654B 新的用于肝脏疾病的非侵入性标记 Liver disease for a new non-invasive marker
01/2012
01/31/2012	US8106164 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
01/26/2012	US20120021464 Thermostable reverse transcriptases and uses thereof
01/17/2012	CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
01/11/2012	EP1629088B1 Prostate stem cell antigen (psca) variants and subsequences thereof
01/10/2012	CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/05/2012	US20120003249 Immuno-molecules containing viral proteins, compositions thereof and methods of using
01/03/2012	US8088982 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
01/03/2012	CA2504327C Templated native silk smectic gels
01/03/2012	CA2420949C Peptide selection method
12/2011
12/29/2011	US20110319869 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
12/28/2011	EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011	EP1572080B1 Fgf variants and methods for use thereof
12/22/2011	US20110311446 Peptides that specifically bind hgf receptor (cmet) and uses thereof
12/22/2011	US20110309831 Side chain deuterated amino acids and methods of use
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	US20110306560 Boronic ester and acid compounds, synthesis and uses
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP1799701B1 Peptide inhibitors of hk2 and their use.
12/07/2011	CN101068563B 新型抗微生物肽 The new antimicrobial peptide
11/2011
11/24/2011	US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
11/24/2011	US20110286928 Methods and compositions for inhibition of BCL6 repression
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8063015 Glycopegylation methods and proteins/peptides produced by the methods
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/16/2011	CN102241742A Peptides and compounds that bind to a thrombopoietin receptor
11/15/2011	CA2252970C Optimization of cells for endogenous gene activation
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
10/2011
10/27/2011	US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/18/2011	US8039438 Amino acid sequences for use in treatment and prevention of cell proliferative disorders; antitumor agents
10/18/2011	CA2381708C Immunogenic protein against piscirickettsia salmonis
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/12/2011	EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110244457 Immuno-amplification
10/05/2011	EP2371859A2 Treatment of TNF alpha related disorders
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	CN101161284B Novel antimicrobial peptides with heparin binding activity
10/04/2011	US8030464 Stabilized bioactive peptides and methods of identification, synthesis, and use
10/04/2011	US8030456 Nogo receptor antagonists
10/04/2011	US8030445 Glycopeptide derivative
09/2011
09/28/2011	EP2368901A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368878A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors
09/28/2011	EP1615945B1 Glycopegylation methods and proteins/peptides produced by the methods
09/27/2011	US8026072 Method of identifying compounds that bind BAFF-R
09/27/2011	CA2537421C Peptides and compounds that bind to thrombopoietin receptor
09/27/2011	CA2336218C Neurotrophic factors
09/21/2011	EP1135408B1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
09/20/2011	US8022190 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents
09/20/2011	CA2473686C Novel cytokine zcytor17 ligand
09/15/2011	US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
09/14/2011	EP1469869B1 Peptide useful in immunomodulation
09/06/2011	US8013156 Tie-2 modulators and methods of use
09/06/2011	US8013128 Antibodies and related molecules that bind to PSCA proteins
09/06/2011	US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines
08/2011
08/31/2011	EP1095140B1 Neurotrophic factors
08/30/2011	US8007810 HLA-A2 tumor associated antigen peptides and compositions
08/24/2011	EP2360174A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
08/24/2011	CN1972746B Separation matrix and method of purification
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/16/2011	US7999095 Nucleic acid supported protein complementation
08/16/2011	US7999071 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine
08/16/2011	US7998738 Integrin-binding antibodies
08/11/2011	US20110196128 Murine zcytor17 ligand polynucleotides
08/10/2011	EP1461079B1 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
08/10/2011	EP1358206B1 Peptide-based compounds
08/10/2011	CN1817906B Antibody against human parathormone related peptides
08/09/2011	US7994287 Antibodies which bind human CXCR3
08/09/2011	CA2334941C Tnf-derived peptides for use in treating oedema
08/04/2011	US20110190224 Non-Viral Delivery of Compounds to Mitochondria
08/03/2011	EP2351768A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands

1 2 3 4 5 6 7 8 9 10 11 12 13 ... 38